Table 2 Etiology and Procedure
From: Optimal patient selection for maze procedure in patients undergoing mitral valve disease
n=43 | Etiology | Procedure | |||
|---|---|---|---|---|---|
Primary MR | 24 (55.8%) | Prolapse | 23 (95.8%) | MVP | 23 (95.8%) |
Rheumatic | 1 (4.2%) | MVR | 1 (4.2%) | ||
Secondary MR | 12 (27.9%) | AF | 8 (66.7%) | MAP | 7 (58.3%) |
Aortic valve disease | 2 (16.7%) | MVP | 1 (8.3%) | ||
Cardiomyopathy | 2 (16.7%) | MVR | 4 (33.3%) | ||
MS | 7 (16.3%) | Rheumatic | 7 (100%) | MVR | 7 (100%) |